147 related articles for article (PubMed ID: 21896815)
1. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.
Gebre T; Ayele B; Zerihun M; House JI; Stoller NE; Zhou Z; Ray KJ; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
Am J Trop Med Hyg; 2011 Sep; 85(3):518-23. PubMed ID: 21896815
[TBL] [Abstract][Full Text] [Related]
2. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
3. The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.
Haile M; Tadesse Z; Gebreselassie S; Ayele B; Gebre T; Yu SN; Stoller NE; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
Am J Trop Med Hyg; 2013 Oct; 89(4):717-20. PubMed ID: 24002488
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
[TBL] [Abstract][Full Text] [Related]
5. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
6. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.
Aragie S; Wittberg DM; Tadesse W; Dagnew A; Hailu D; Chernet A; Melo JS; Aiemjoy K; Haile M; Zeru T; Tadesse Z; Gwyn S; Martin DL; Arnold BF; Freeman MC; Nash SD; Callahan EK; Porco TC; Lietman TM; Keenan JD
Lancet Glob Health; 2022 Jan; 10(1):e87-e95. PubMed ID: 34919861
[TBL] [Abstract][Full Text] [Related]
7. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
[TBL] [Abstract][Full Text] [Related]
8. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.
Stoller NE; Gebre T; Ayele B; Zerihun M; Assefa Y; Habte D; Zhou Z; Porco TC; Keenan JD; House JI; Gaynor BD; Lietman TM; Emerson PM
Int Health; 2011 Jun; 3(2):75-84. PubMed ID: 21785663
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
11. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
Keenan JD; See CW; Moncada J; Ayele B; Gebre T; Stoller NE; McCulloch CE; Porco TC; Gaynor BD; Emerson PM; Schachter J; Lietman TM
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):235-40. PubMed ID: 22159017
[TBL] [Abstract][Full Text] [Related]
13. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
[TBL] [Abstract][Full Text] [Related]
14. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
[TBL] [Abstract][Full Text] [Related]
15. Effect of a community intervention with pit latrines in five districts of Amhara, Ethiopia.
Ngondi J; Teferi T; Gebre T; Shargie EB; Zerihun M; Ayele B; Adamu L; King JD; Cromwell EA; Emerson PM
Trop Med Int Health; 2010 May; 15(5):592-9. PubMed ID: 20345557
[TBL] [Abstract][Full Text] [Related]
16. Childhood mortality in a cohort treated with mass azithromycin for trachoma.
Keenan JD; Ayele B; Gebre T; Zerihun M; Zhou Z; House JI; Gaynor BD; Porco TC; Emerson PM; Lietman TM
Clin Infect Dis; 2011 Apr; 52(7):883-8. PubMed ID: 21427395
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma.
Ngondi J; Gebre T; Shargie EB; Adamu L; Ejigsemahu Y; Teferi T; Zerihun M; Ayele B; Cevallos V; King J; Emerson PM
Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1001-10. PubMed ID: 19178920
[TBL] [Abstract][Full Text] [Related]
19. Adverse events after mass azithromycin treatments for trachoma in Ethiopia.
Ayele B; Gebre T; House JI; Zhou Z; McCulloch CE; Porco TC; Gaynor BD; Emerson PM; Lietman TM; Keenan JD
Am J Trop Med Hyg; 2011 Aug; 85(2):291-4. PubMed ID: 21813850
[TBL] [Abstract][Full Text] [Related]
20. Active trachoma and community use of sanitation, Ethiopia.
Oswald WE; Stewart AE; Kramer MR; Endeshaw T; Zerihun M; Melak B; Sata E; Gessese D; Teferi T; Tadesse Z; Guadie B; King JD; Emerson PM; Callahan EK; Flanders D; Moe CL; Clasen TF
Bull World Health Organ; 2017 Apr; 95(4):250-260. PubMed ID: 28479620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
